Oncolytics Biotech (ONCY) vs ProMIS Neurosciences (PMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ProMIS Neurosciences (PMN) has outperformed Oncolytics Biotech (ONCY) over the past year, losing 32.4% versus a loss of 55.9%. Over five years, ONCY leads with a -73.2% price change compared with -95.9% for PMN. ProMIS Neurosciences is the larger company by market cap ($82.1 million vs $71.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ONCY | PMN |
|---|---|---|
| Share price | $0.5444 | $9.15 |
| Market cap | $71.38M | $82.05M |
| 1-day change | -8.63% | +0.33% |
| YTD return | -31.52% | +33.53% |
| 1-year return | -55.87% | -32.44% |
| 5-year return | -73.16% | -95.95% |
| EPS (TTM) | $-0.35 | $-11.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.32 | $27.40 |
| 52-week low | $0.5418 | $6.27 |
| Distance from 52-week high | -58.76% | -66.61% |
| Average volume | 1.10M | 84.01K |
| Shares outstanding | 131.12M | 8.97M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMN has outperformed ONCY by 23.4 percentage points over the past year.
ONCY vs PMN FAQ
Which is bigger, Oncolytics Biotech or ProMIS Neurosciences?
ProMIS Neurosciences (PMN) is larger, with a market capitalization of $82.05M compared with $71.38M for Oncolytics Biotech (ONCY).
Which stock has performed better over the past year, ONCY or PMN?
PMN returned -32.44% over the past 12 months, compared with -55.87% for ONCY (price return, excluding dividends). Past performance does not predict future results.
Are Oncolytics Biotech and ProMIS Neurosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.